Evaluating the Cardiovascular Event Profile After Administration of Tixagevimab and Cilgavimab (Evusheld) in Lung Transplant Recipients

被引:0
|
作者
Bulger, J. L. [1 ]
Ching, K. [2 ]
Joyce, C. [3 ]
Warrior, K. [1 ]
机构
[1] Loyola Univ Med Ctr, Pulm Crit Care, Maywood, IL USA
[2] Loyola Univ Med Ctr, Internal Med, Maywood, IL USA
[3] Loyola Univ Med Ctr, Ctr Translat Res & Educ, Maywood, IL USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A6578
引用
收藏
页数:3
相关论文
共 50 条
  • [21] A rapid decline in the anti-receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration
    Benotmane, Ilies
    Velay, Aurelie
    Vargas, Gabriela-Gautier
    Olagne, Jerome
    Cognard, Noelle
    Heibel, Francoise
    Braun-Parvez, Laura
    Martzloff, Jonas
    Perrin, Peggy
    Pszczolinsk, Romain
    Moulin, Bruno
    Fafi-Kremer, Samira
    Caillard, Sophie
    KIDNEY INTERNATIONAL, 2022, 102 (05) : 1188 - +
  • [22] Evusheld Protects Against SARS-CoV-2 in Lung Transplant Recipients
    Eck, D.
    Chapin, K.
    Siedlecki, A.
    Barnes, J.
    Trindade, A.
    Shaver, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S514 - S514
  • [23] Safety, Effectiveness, and Perceptions of Tixagevimab and Cilgavimab Among Solid Organ Transplant Recipients: Focus on Patient-Reported Outcomes
    Alejo, Jennifer
    Kim, Jake
    Chiang, Teresa
    Avery, Robin
    Karaba, Andrew
    Jefferis, Alexa
    Warren, Daniel
    Massie, Allan
    Tobian, Aaron
    Segev, Dorry
    Werbel, William
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (01) : S19 - S20
  • [24] Real-world experience of tixagevimab-cilgavimab pre-exposure prophylaxis in orthotopic heart transplant recipients
    Ordaya, Eloy E.
    Higgins, Eibhlin M.
    Vergidis, Paschalis
    Razonable, Raymund R.
    Beam, Elena
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (03)
  • [25] A single-center review of pre-exposure prophylaxis with tixagevimab-cilgavimab in solid organ transplant recipients
    Morado, Faiza
    Davoudi, Roland
    Kawewat-Ho, Pnada
    Nanda, Neha
    Cartus, Rachel
    Shaikh, Suhail A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (04)
  • [26] Pre-Exposure Tixagevimab/Cilgavimab Monoclonal Antibodies Reduces Covid-19 Infection in Heart Transplant Recipients
    White, Z.
    Leeds, J.
    Doyle, A.
    Maddox, M.
    Bergin, J.
    Sharma, B.
    Rao, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S662 - S662
  • [27] Tixagevimab-Cilgavimab Decreases the Rate of SARS-CoV-2 Infection Among Solid Organ Transplant Recipients
    Sanayei, Ava M.
    Montalvan, Adriana
    Faria, Isabella
    Ochalla, Julia
    Pavlakis, Martha
    Blair, Barbra M.
    Alonso, Carolyn D.
    Curry, Michael
    Saberi, Behnam
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (08) : 1784 - 1792
  • [28] Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort study
    Simone, Simona
    Pronzo, Virginia
    Pesce, Francesco
    Bavaro, Davide Fiore
    Infante, Barbara
    Mercuri, Silvia
    Schirinzi, Annalisa
    Panaro, Antonella
    Conte, Eleonora
    Belati, Alessandra
    Troise, Dario
    Pontrelli, Paola
    Conserva, Francesca
    Gallo, Pasquale
    Panico, Maddalena
    Spilotros, Marco
    Lucarelli, Giuseppe
    Saracino, Annalisa
    Stallone, Giovanni
    Di Serio, Francesca
    Ditonno, Pasquale
    Gesualdo, Loreto
    JOURNAL OF NEPHROLOGY, 2024, 37 (06) : 1539 - 1550
  • [29] Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients
    Benotmane, Ilies
    Velay, Aurelie
    Gautier-Vargas, Gabriela
    Olagne, Jerome
    Obrecht, Augustin
    Cognard, Noelle
    Heibel, Francoise
    Braun-Parvez, Laura
    Keller, Nicolas
    Martzloff, Jonas
    Perrin, Peggy
    Pszczolinski, Romain
    Moulin, Bruno
    Fafi-Kremer, Samira
    Thaunat, Olivier
    Caillard, Sophie
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (11) : 2675 - 2681
  • [30] Investigation of severe acute respiratory syndrome coronavirus 2 infection status in solid organ transplant recipients treated with tixagevimab/ cilgavimab
    Aihara, Ririka
    Umemura, Keisuke
    Katada, Yoshiki
    Nakagawa, Shunsaku
    Kobayashi, Takashi
    Hatano, Etsuro
    Date, Hiroshi
    Nagao, Miki
    Terada, Tomohiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (12) : 1222 - 1227